Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant TNF alpha (Golimumab Biosimilar) antibody

This Human Monoclonal antibody specifically detects TNF alpha (Golimumab Biosimilar) in not_set. It exhibits reactivity toward Human.
Catalog No. ABIN7597725
-15% Promotion 2026
$340.97
$401.14
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to: United States
Delivery in 12 to 14 Business Days

Quick Overview for Recombinant TNF alpha (Golimumab Biosimilar) antibody (ABIN7597725)

Target

TNF alpha (Golimumab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 2
Human

Clonality

  • 2
Monoclonal

Conjugate

  • 1
  • 1
This TNF alpha (Golimumab Biosimilar) antibody is un-conjugated

Application

Please inquire

Grade

Research Grade
  • Expression System

    Mammalian cells

    Purpose

    Research Grade Golimumab Biosimilar Antibody

    Specificity

    TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1

    Purification

    Protein A or G purified from cell culture supernatant.

    Purity

    >95 % by SDS-PAGE.

    Isotype

    IgG1 kappa
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1.3 mg/mL

    Buffer

    0.01M PBS, pH 7.4.

    Storage

    4 °C,-20 °C,-80 °C

    Storage Comment

    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

    Expiry Date

    12 months
  • Target

    TNF alpha (Golimumab Biosimilar)

    Alternative Name

    Golimumab Biosimilar

    Target Type

    Biosimilar

    Background

    TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1

    UniProt

    P01375

    CAS-No

    476181-74-5
You are here:
Chat with us!